Halobetasol propionate lotion 0.05% in patients 12 to 16 years 11 months of age with plaque psoriasis: Results of an open-label study evaluating adrenal suppression potential

BACKGROUND: The effects of halobetasol propionate (HBP) lotion 0.05% on the hypothalamic-pituitary-adrenal (HPA) axis have not been previously evaluated in adolescents. OBJECTIVE: To examine the effect of HBP on HPA axis suppression in patients aged <17 years with plaque psoriasis. METHODS: In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Laquer, Vivian, Nguyen, Andrea, Squittieri, Nicholas, Nguyen, Tien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626834/
https://www.ncbi.nlm.nih.gov/pubmed/34870246
http://dx.doi.org/10.1016/j.jdin.2021.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626834/
https://www.ncbi.nlm.nih.gov/pubmed/34870246
http://dx.doi.org/10.1016/j.jdin.2021.10.003

Ejemplares similares